Active ingredientParitaprevirCat. No. P-P025-001CAS 1216941-48-8Family · Pharmaceutical analytical standards
Paritaprevir
An inhibitor of the hepatitis C virus NS3/4A protease, approved in December 2014 in the United States and in 2015 in Europe in combination with ombitasvir, with or without dasabuvir: these oral therapies reach cure rates of around 95%. This family brings together the active ingredient.
Did you know?It is always given with a small dose of ritonavir, an antiviral born for HIV that here acts only as a booster: it slows the breakdown of paritaprevir and raises its blood levels.
Go to the active ingredient →Active ingredientParitaprevirCat. No. P-P025-001CAS 1216941-48-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.